Small Molecule Epigenetic Modulators in Pure Chemical Cell Fate Conversion
Although innovative technologies for somatic cell reprogramming and transdifferentiation provide new strategies for the research of translational medicine, including disease modeling, drug screening, artificial organ development, and cell therapy, recipient safety remains a concern due to the use of...
Saved in:
Main Authors: | Zhao-Di Yuan (Author), Wei-Ning Zhu (Author), Ke-Zhi Liu (Author), Zhan-Peng Huang (Author), Yan-Chuang Han (Author) |
---|---|
Format: | Book |
Published: |
Hindawi Limited,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Modulation of protein fate decision by small molecules: targeting molecular chaperone machinery
by: Lei Wang, et al.
Published: (2020) -
Stilbenes: a promising small molecule modulator for epigenetic regulation in human diseases
by: Jing Tian, et al.
Published: (2023) -
The Impact of Epigenetic Signatures on Amniotic Fluid Stem Cell Fate
by: Daniela Di Tizio, et al.
Published: (2018) -
Epigenetic Regulation of Dental Pulp Stem Cell Fate
by: Dan Zhou, et al.
Published: (2020) -
Small-Molecule Inhibitors Overcome Epigenetic Reprogramming for Cancer Therapy
by: Wenjing Xiao, et al.
Published: (2021)